Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.4K
Gene Therapy00:59

Gene Therapy

27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Group Therapy01:26

Group Therapy

433
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
433
Cancer Therapies02:49

Cancer Therapies

10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Behavior Therapy01:22

Behavior Therapy

702
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
702

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pregnancy-associated progression with spontaneous postpartum regression in metastatic alveolar soft part sarcoma.

BMJ case reports·2026
Same author

The Anesthesia Preparedeness Clinic (APC) triage score tool: an integrated electronic health record tool for improving resource allocation for preoperative care clinics.

Journal of clinical monitoring and computing·2026
Same author

A pre-trained language model approach for triaging surgical patients for preoperative anesthesia clinics.

Journal of clinical monitoring and computing·2025
Same author

Comparative Outcomes of Brachyury Vaccine vs. Imatinib in Advanced Chordoma: A Mayo Clinic Experience.

Cancers·2025
Same author

The State of Remote Patient Monitoring for Chronic Disease Management in the United States.

Journal of medical Internet research·2025
Same author

Balancing Act: Generative AI Tools and Scope of Practice in Health Coaching.

American journal of health promotion : AJHP·2025

Related Experiment Video

Updated: Jan 30, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

15.2K

First-Line Therapy for Metastatic Soft Tissue Sarcoma.

Megan Meyer1, Mahesh Seetharam2

  • 1Internal Medicine, Mayo Clinic, 5777 E Mayo Blvd., Phoenix, AZ, 85054, USA.

Current Treatment Options in Oncology
|January 25, 2019
PubMed
Summary
This summary is machine-generated.

Soft tissue sarcomas are rare, diverse cancers. Current treatments for metastatic disease include chemotherapy and targeted therapies, with immunotherapy showing promise for specific subtypes.

Keywords:
First line treatmentMetastatic soft tissue sarcomaTargeted therapies

More Related Videos

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.3K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.9K

Related Experiment Videos

Last Updated: Jan 30, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

15.2K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.3K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.9K

Area of Science:

  • Oncology
  • Cancer Research
  • Sarcoma Biology

Background:

  • Soft tissue sarcomas (STS) are rare cancers, comprising less than 1% of all cancer diagnoses.
  • STS encompasses over 75 heterogeneous subtypes, each with unique biological characteristics and treatment responses.
  • The rarity and diversity of STS necessitate a personalized, multidisciplinary approach to treatment, often at specialized centers.

Purpose of the Study:

  • To summarize current data on approved therapies for metastatic soft tissue sarcoma, focusing on first-line treatments.
  • To review recent advancements and emerging therapies, including immunotherapy and targeted agents.
  • To highlight the importance of molecular characterization in understanding STS heterogeneity and improving treatment strategies.

Main Methods:

  • Review of existing literature and clinical trial data on approved therapies for metastatic STS.
  • Analysis of outcomes for first-line treatments, including chemotherapy, targeted agents, and immunotherapy.
  • Examination of recent data on novel agents and combinations, such as PDGFR-targeted antibodies.

Main Results:

  • Established first-line therapies for metastatic STS include anthracyclines and ifosfamide, with limited median overall survival.
  • Recent approvals of trabectedin, eribulin, and pazopanib offer improved outcomes for select histologic subtypes.
  • Immunotherapy demonstrates encouraging activity in specific sarcoma subtypes, prompting further investigation in combination therapies.

Conclusions:

  • Personalized treatment strategies, informed by molecular characterization, are crucial for improving outcomes in diverse STS subtypes.
  • Emerging therapies like immunotherapy and targeted agents represent significant advancements in metastatic STS management.
  • Continued research into the molecular underpinnings of STS is essential for developing more effective treatments and improving patient survival.